【調査レポート】迅速抗菌薬感受性試験の世界市場2023-2029：抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他

• 英文タイトル：Global Rapid Antimicrobial Susceptibility Testing Market Growth 2023-2029

LP Informationが調査・発行した産業分析レポートです。迅速抗菌薬感受性試験の世界市場2023-2029：抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他 / Global Rapid Antimicrobial Susceptibility Testing Market Growth 2023-2029 / MRCLP3DB2330資料のイメージです。

• レポートコード：MRCLP3DB2330
• 出版社/出版日：LP Information / 2023年12月
• レポート形態：英文、PDF、128ページ
• 納品方法：Eメール（納期：2-3営業日）
• 産業分類：医療機器＆消耗品

• 販売価格（消費税別）

Single User	￥549,000 (USD3,660)	▷ お問い合わせ
Corporate User	￥1,098,000 (USD7,320)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

LPインフォメーション社の最新調査レポート「迅速抗菌薬感受性試験の世界市場」は、過去の販売実績から2022年の世界の迅速抗菌薬感受性試験の総販売量を検討し、2023年から2029年の予測される迅速抗菌薬感受性試験の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の迅速抗菌薬感受性試験の市場規模を掲載し、XXX百万米ドル規模の世界の迅速抗菌薬感受性試験市場の詳細な分析を提供します。本インサイトレポートは、世界の迅速抗菌薬感受性試験業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本資料では、加速する世界の迅速抗菌薬感受性試験市場における各社の独自のポジションをより深く理解するために、迅速抗菌薬感受性試験製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の迅速抗菌薬感受性試験市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。迅速抗菌薬感受性試験の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。迅速抗菌薬感受性試験の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。迅速抗菌薬感受性試験の欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

迅速抗菌薬感受性試験の世界主要メーカーとしては、BioMérieux、 BD、 Thermo Fisher Scientific、 Danaher、 Bio-Rad Laboratories、 Bruker、 Roche Diagnostics、 Accelerate Diagnostics、 Merck、 HiMedia Laboratories、 Liofilchem S.R.L Diagnostics、 Alifax S.r.l.、 Creative Diagnostics、 Synbiosis、 Bioanalyse、 ZHUHAI DL BIOTECH、 ELITechGroup、 Mast Group、 CONDALAB、 Genefluidics、 Biotron、 InvivoGen、 MP Biomedicals、 QuantaMatrix、 PML Microbiologicalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の迅速抗菌薬感受性試験市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

本調査では迅速抗菌薬感受性試験市場をセグメンテーションし、種類別 (抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他)、用途別 (臨床診断、創薬、その他)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他

・用途別区分：臨床診断、創薬、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
欧州（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の迅速抗菌薬感受性試験市場の10年間の市場状況・展望は？
・世界および地域別に見た迅速抗菌薬感受性試験市場成長の要因は何か？
・迅速抗菌薬感受性試験の市場機会はエンドマーケットの規模によってどのように変化するのか？
・迅速抗菌薬感受性試験のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：迅速抗菌薬感受性試験の年間販売量2018-2029、地域別現状・将来分析
・迅速抗菌薬感受性試験の種類別セグメント：抗菌薬感受性検査、抗真菌薬感受性検査、駆虫薬感受性検査、その他
・迅速抗菌薬感受性試験の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・迅速抗菌薬感受性試験の用途別セグメント：臨床診断、創薬、その他
・迅速抗菌薬感受性試験の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の迅速抗菌薬感受性試験市場
・企業別のグローバル迅速抗菌薬感受性試験市場データ：2018-2023年の年間販売量、市場シェア
・企業別の迅速抗菌薬感受性試験の年間売上：2018-2023年の売上、市場シェア
・企業別の迅速抗菌薬感受性試験販売価格
・主要企業の迅速抗菌薬感受性試験生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

迅速抗菌薬感受性試験の地域別レビュー
・地域別の迅速抗菌薬感受性試験市場規模2018-2023：年間販売量、売上
・主要国別の迅速抗菌薬感受性試験市場規模2018-2023：年間販売量、売上
・南北アメリカの迅速抗菌薬感受性試験販売の成長
・アジア太平洋の迅速抗菌薬感受性試験販売の成長
・欧州の迅速抗菌薬感受性試験販売の成長
・中東・アフリカの迅速抗菌薬感受性試験販売の成長

南北アメリカ市場
・南北アメリカの国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・南北アメリカの迅速抗菌薬感受性試験の種類別販売量
・南北アメリカの迅速抗菌薬感受性試験の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・アジア太平洋の迅速抗菌薬感受性試験の種類別販売量
・アジア太平洋の迅速抗菌薬感受性試験の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

欧州市場
・欧州の国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・欧州の迅速抗菌薬感受性試験の種類別販売量
・欧州の迅速抗菌薬感受性試験の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の迅速抗菌薬感受性試験販売量、売上（2018-2023）
・中東・アフリカの迅速抗菌薬感受性試験の種類別販売量
・中東・アフリカの迅速抗菌薬感受性試験の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・迅速抗菌薬感受性試験の製造コスト構造分析
・迅速抗菌薬感受性試験の製造プロセス分析
・迅速抗菌薬感受性試験の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・迅速抗菌薬感受性試験の主要なグローバル販売業者
・迅速抗菌薬感受性試験の主要なグローバル顧客

地域別の迅速抗菌薬感受性試験市場予測レビュー
・地域別の迅速抗菌薬感受性試験市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・欧州の国別予測
・迅速抗菌薬感受性試験の種類別市場規模予測
・迅速抗菌薬感受性試験の用途別市場規模予測

主要企業分析
BioMérieux、 BD、 Thermo Fisher Scientific、 Danaher、 Bio-Rad Laboratories、 Bruker、 Roche Diagnostics、 Accelerate Diagnostics、 Merck、 HiMedia Laboratories、 Liofilchem S.R.L Diagnostics、 Alifax S.r.l.、 Creative Diagnostics、 Synbiosis、 Bioanalyse、 ZHUHAI DL BIOTECH、 ELITechGroup、 Mast Group、 CONDALAB、 Genefluidics、 Biotron、 InvivoGen、 MP Biomedicals、 QuantaMatrix、 PML Microbiologicals
・企業情報
・迅速抗菌薬感受性試験製品
・迅速抗菌薬感受性試験販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rapid Antimicrobial Susceptibility Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rapid Antimicrobial Susceptibility Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rapid Antimicrobial Susceptibility Testing players cover BioMérieux, BD, Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, Bruker, Roche Diagnostics, Accelerate Diagnostics and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Susceptibility testing is used to determine which antimicrobials will inhibit the growth of the bacteria or fungi causing a specific infection.
LPI (LP Information)’ newest research report, the “Rapid Antimicrobial Susceptibility Testing Industry Forecast” looks at past sales and reviews total world Rapid Antimicrobial Susceptibility Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Antimicrobial Susceptibility Testing sales for 2023 through 2029. With Rapid Antimicrobial Susceptibility Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Antimicrobial Susceptibility Testing industry.
This Insight Report provides a comprehensive analysis of the global Rapid Antimicrobial Susceptibility Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Antimicrobial Susceptibility Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Antimicrobial Susceptibility Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Antimicrobial Susceptibility Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Antimicrobial Susceptibility Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antimicrobial Susceptibility Testing market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Others
Segmentation by application
Clinical Diagnostics
Drug Development
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioMérieux
BD
Thermo Fisher Scientific
Danaher
Bio-Rad Laboratories
Bruker
Roche Diagnostics
Accelerate Diagnostics
Merck
HiMedia Laboratories
Liofilchem S.R.L Diagnostics
Alifax S.r.l.
Creative Diagnostics
Synbiosis
Bioanalyse
ZHUHAI DL BIOTECH
ELITechGroup
Mast Group
CONDALAB
Genefluidics
Biotron
InvivoGen
MP Biomedicals
QuantaMatrix
PML Microbiologicals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rapid Antimicrobial Susceptibility Testing market?
What factors are driving Rapid Antimicrobial Susceptibility Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rapid Antimicrobial Susceptibility Testing market opportunities vary by end market size?
How does Rapid Antimicrobial Susceptibility Testing break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

レポート目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rapid Antimicrobial Susceptibility Testing by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rapid Antimicrobial Susceptibility Testing by Country/Region, 2018, 2022 & 2029
2.2 Rapid Antimicrobial Susceptibility Testing Segment by Type
2.2.1 Antibacterial Susceptibility Testing
2.2.2 Antifungal Susceptibility Testing
2.2.3 Antiparasitic Susceptibility Testing
2.2.4 Others
2.3 Rapid Antimicrobial Susceptibility Testing Sales by Type
2.3.1 Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Type (2018-2023)
2.3.2 Global Rapid Antimicrobial Susceptibility Testing Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rapid Antimicrobial Susceptibility Testing Sale Price by Type (2018-2023)
2.4 Rapid Antimicrobial Susceptibility Testing Segment by Application
2.4.1 Clinical Diagnostics
2.4.2 Drug Development
2.4.3 Other
2.5 Rapid Antimicrobial Susceptibility Testing Sales by Application
2.5.1 Global Rapid Antimicrobial Susceptibility Testing Sale Market Share by Application (2018-2023)
2.5.2 Global Rapid Antimicrobial Susceptibility Testing Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rapid Antimicrobial Susceptibility Testing Sale Price by Application (2018-2023)
3 Global Rapid Antimicrobial Susceptibility Testing by Company
3.1 Global Rapid Antimicrobial Susceptibility Testing Breakdown Data by Company
3.1.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales by Company (2018-2023)
3.1.2 Global Rapid Antimicrobial Susceptibility Testing Sales Market Share by Company (2018-2023)
3.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue by Company (2018-2023)
3.2.1 Global Rapid Antimicrobial Susceptibility Testing Revenue by Company (2018-2023)
3.2.2 Global Rapid Antimicrobial Susceptibility Testing Revenue Market Share by Company (2018-2023)
3.3 Global Rapid Antimicrobial Susceptibility Testing Sale Price by Company
3.4 Key Manufacturers Rapid Antimicrobial Susceptibility Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rapid Antimicrobial Susceptibility Testing Product Location Distribution
3.4.2 Players Rapid Antimicrobial Susceptibility Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rapid Antimicrobial Susceptibility Testing by Geographic Region
4.1 World Historic Rapid Antimicrobial Susceptibility Testing Market Size by Geographic Region (2018-2023)
4.1.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rapid Antimicrobial Susceptibility Testing Market Size by Country/Region (2018-2023)
4.2.1 Global Rapid Antimicrobial Susceptibility Testing Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rapid Antimicrobial Susceptibility Testing Sales Growth
4.4 APAC Rapid Antimicrobial Susceptibility Testing Sales Growth
4.5 Europe Rapid Antimicrobial Susceptibility Testing Sales Growth
4.6 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales Growth
5 Americas
5.1 Americas Rapid Antimicrobial Susceptibility Testing Sales by Country
5.1.1 Americas Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023)
5.1.2 Americas Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023)
5.2 Americas Rapid Antimicrobial Susceptibility Testing Sales by Type
5.3 Americas Rapid Antimicrobial Susceptibility Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Antimicrobial Susceptibility Testing Sales by Region
6.1.1 APAC Rapid Antimicrobial Susceptibility Testing Sales by Region (2018-2023)
6.1.2 APAC Rapid Antimicrobial Susceptibility Testing Revenue by Region (2018-2023)
6.2 APAC Rapid Antimicrobial Susceptibility Testing Sales by Type
6.3 APAC Rapid Antimicrobial Susceptibility Testing Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rapid Antimicrobial Susceptibility Testing by Country
7.1.1 Europe Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023)
7.1.2 Europe Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023)
7.2 Europe Rapid Antimicrobial Susceptibility Testing Sales by Type
7.3 Europe Rapid Antimicrobial Susceptibility Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rapid Antimicrobial Susceptibility Testing by Country
8.1.1 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Revenue by Country (2018-2023)
8.2 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Type
8.3 Middle East & Africa Rapid Antimicrobial Susceptibility Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rapid Antimicrobial Susceptibility Testing
10.3 Manufacturing Process Analysis of Rapid Antimicrobial Susceptibility Testing
10.4 Industry Chain Structure of Rapid Antimicrobial Susceptibility Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rapid Antimicrobial Susceptibility Testing Distributors
11.3 Rapid Antimicrobial Susceptibility Testing Customer
12 World Forecast Review for Rapid Antimicrobial Susceptibility Testing by Geographic Region
12.1 Global Rapid Antimicrobial Susceptibility Testing Market Size Forecast by Region
12.1.1 Global Rapid Antimicrobial Susceptibility Testing Forecast by Region (2024-2029)
12.1.2 Global Rapid Antimicrobial Susceptibility Testing Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rapid Antimicrobial Susceptibility Testing Forecast by Type
12.7 Global Rapid Antimicrobial Susceptibility Testing Forecast by Application
13 Key Players Analysis
13.1 BioMérieux
13.1.1 BioMérieux Company Information
13.1.2 BioMérieux Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.1.3 BioMérieux Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioMérieux Main Business Overview
13.1.5 BioMérieux Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.2.3 BD Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Information
13.3.2 Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.3.3 Thermo Fisher Scientific Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Thermo Fisher Scientific Main Business Overview
13.3.5 Thermo Fisher Scientific Latest Developments
13.4 Danaher
13.4.1 Danaher Company Information
13.4.2 Danaher Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.4.3 Danaher Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Danaher Main Business Overview
13.4.5 Danaher Latest Developments
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Information
13.5.2 Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.5.3 Bio-Rad Laboratories Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bio-Rad Laboratories Main Business Overview
13.5.5 Bio-Rad Laboratories Latest Developments
13.6 Bruker
13.6.1 Bruker Company Information
13.6.2 Bruker Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.6.3 Bruker Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bruker Main Business Overview
13.6.5 Bruker Latest Developments
13.7 Roche Diagnostics
13.7.1 Roche Diagnostics Company Information
13.7.2 Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.7.3 Roche Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Roche Diagnostics Main Business Overview
13.7.5 Roche Diagnostics Latest Developments
13.8 Accelerate Diagnostics
13.8.1 Accelerate Diagnostics Company Information
13.8.2 Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.8.3 Accelerate Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Accelerate Diagnostics Main Business Overview
13.8.5 Accelerate Diagnostics Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.9.3 Merck Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 HiMedia Laboratories
13.10.1 HiMedia Laboratories Company Information
13.10.2 HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.10.3 HiMedia Laboratories Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 HiMedia Laboratories Main Business Overview
13.10.5 HiMedia Laboratories Latest Developments
13.11 Liofilchem S.R.L Diagnostics
13.11.1 Liofilchem S.R.L Diagnostics Company Information
13.11.2 Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.11.3 Liofilchem S.R.L Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Liofilchem S.R.L Diagnostics Main Business Overview
13.11.5 Liofilchem S.R.L Diagnostics Latest Developments
13.12 Alifax S.r.l.
13.12.1 Alifax S.r.l. Company Information
13.12.2 Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.12.3 Alifax S.r.l. Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Alifax S.r.l. Main Business Overview
13.12.5 Alifax S.r.l. Latest Developments
13.13 Creative Diagnostics
13.13.1 Creative Diagnostics Company Information
13.13.2 Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.13.3 Creative Diagnostics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Creative Diagnostics Main Business Overview
13.13.5 Creative Diagnostics Latest Developments
13.14 Synbiosis
13.14.1 Synbiosis Company Information
13.14.2 Synbiosis Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.14.3 Synbiosis Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Synbiosis Main Business Overview
13.14.5 Synbiosis Latest Developments
13.15 Bioanalyse
13.15.1 Bioanalyse Company Information
13.15.2 Bioanalyse Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.15.3 Bioanalyse Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Bioanalyse Main Business Overview
13.15.5 Bioanalyse Latest Developments
13.16 ZHUHAI DL BIOTECH
13.16.1 ZHUHAI DL BIOTECH Company Information
13.16.2 ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.16.3 ZHUHAI DL BIOTECH Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 ZHUHAI DL BIOTECH Main Business Overview
13.16.5 ZHUHAI DL BIOTECH Latest Developments
13.17 ELITechGroup
13.17.1 ELITechGroup Company Information
13.17.2 ELITechGroup Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.17.3 ELITechGroup Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 ELITechGroup Main Business Overview
13.17.5 ELITechGroup Latest Developments
13.18 Mast Group
13.18.1 Mast Group Company Information
13.18.2 Mast Group Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.18.3 Mast Group Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Mast Group Main Business Overview
13.18.5 Mast Group Latest Developments
13.19 CONDALAB
13.19.1 CONDALAB Company Information
13.19.2 CONDALAB Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.19.3 CONDALAB Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 CONDALAB Main Business Overview
13.19.5 CONDALAB Latest Developments
13.20 Genefluidics
13.20.1 Genefluidics Company Information
13.20.2 Genefluidics Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.20.3 Genefluidics Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Genefluidics Main Business Overview
13.20.5 Genefluidics Latest Developments
13.21 Biotron
13.21.1 Biotron Company Information
13.21.2 Biotron Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.21.3 Biotron Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Biotron Main Business Overview
13.21.5 Biotron Latest Developments
13.22 InvivoGen
13.22.1 InvivoGen Company Information
13.22.2 InvivoGen Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.22.3 InvivoGen Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 InvivoGen Main Business Overview
13.22.5 InvivoGen Latest Developments
13.23 MP Biomedicals
13.23.1 MP Biomedicals Company Information
13.23.2 MP Biomedicals Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.23.3 MP Biomedicals Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 MP Biomedicals Main Business Overview
13.23.5 MP Biomedicals Latest Developments
13.24 QuantaMatrix
13.24.1 QuantaMatrix Company Information
13.24.2 QuantaMatrix Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.24.3 QuantaMatrix Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 QuantaMatrix Main Business Overview
13.24.5 QuantaMatrix Latest Developments
13.25 PML Microbiologicals
13.25.1 PML Microbiologicals Company Information
13.25.2 PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Product Portfolios and Specifications
13.25.3 PML Microbiologicals Rapid Antimicrobial Susceptibility Testing Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 PML Microbiologicals Main Business Overview
13.25.5 PML Microbiologicals Latest Developments
14 Research Findings and Conclusion